News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Nepal glacier collapse has killed at least 1,204 people and left more than 4,200 missing.
  • Officials say about 7,500 homes were destroyed and roughly 20,000 dwellings will need rebuilding.
  • Rescue teams and international experts continue searching hydropower tunnels for survivors.
  • Gaza farmers rebuilt a local seed bank to preserve heirloom crops on the territory's remaining cultivable land.
  • Aid workers warn the rebuilt seed stock covers only a fraction of Gaza's agricultural needs.
  • Bitcoin paused below $78,000 as traders awaited U.S. regulatory decisions.
  • Renewed U.S.-Iran tensions are increasing geopolitical risk and weighing on market sentiment.

Latest Articles

NVE Corp Director Daniel Baker Offloads $623K in Strategic Share Reduction

NVE Corp Director Daniel Baker Offloads $623K in Strategic Share Reduction

NVE Corp director Daniel A. Baker recently executed a series of equity sales totaling $623,217, reducing his direct stake while the company reports accelerated financial growth and a sharp run-up in share valuation. The transactions unfold as NVEC navigates strong gross margins and rapid revenue expansion, though current pricing metrics suggest pot…

HUTCHMED Announces NMPA Approval for ATLED® (Fanregratinib) for the Treatment of Patients with FGFR2-Fusion/Rearrangement Intrahepatic Cholangiocarcinoma

HUTCHMED Announces NMPA Approval for ATLED® (Fanregratinib) for the Treatment of Patients with FGFR2-Fusion/Rearrangement Intrahepatic Cholangiocarcinoma

HUTCHMED announces that China's NMPA has conditionally approved ATLED® (fanregratinib), a selective FGFR1/2/3 inhibitor, for adult patients with advanced or metastatic intrahepatic cholangiocarcinoma (ICC) harboring FGFR2 fusions/rearrangements after prior systemic therapy. The approval is based on strong Phase II clinical data showing significant …

Healthy Choice Wellness Corp. Announces 1-for-35 Reverse Stock Split

Healthy Choice Wellness Corp. Announces 1-for-35 Reverse Stock Split

Healthy Choice Wellness Corp. (NYSE American: HCWC), a natural and organic grocery sector holding company, declared a 1-for-35 reverse stock split effective August 28, 2026. The split aims to elevate the stock price to comply with NYSE American's minimum $4.00 share price requirement following an anticipated merger with Host Digital Infrastructure …

S&P Upgrades ICU Medical to BB as Leverage Falls and Cash Flow Strengthens

S&P Upgrades ICU Medical to BB as Leverage Falls and Cash Flow Strengthens

S&P Global Ratings raised ICU Medical Inc.'s corporate credit rating to BB from BB- after the infusion-therapy supplier showed meaningful deleveraging and stronger free operating cash flow. Key drivers included the companys use of proceeds from a 2025 divestiture and additional cash flow-driven debt repayments in the second quarter of 2026. S&Ps …

Koss Corporation Releases Fourth Quarter and Full Year Results

Koss Corporation Releases Fourth Quarter and Full Year Results

Koss Corporation announced its financial results for Q4 and fiscal year ended June 30, 2026, showing a 5.8% increase in Q4 net sales and a net income turnaround to $476,801 from a net loss the previous year. Fiscal year sales grew 3.1%, aided by custom headphones sales to the education sector and strong domestic direct-to-consumer and distributor s…

McEwen Copper Completes US$240 Million Term Loan to Advance Los Azules Toward Final Investment Decision

McEwen Copper Completes US$240 Million Term Loan to Advance Los Azules Toward Final Investment Decision

McEwen Inc., via its majority-owned subsidiary McEwen Copper, has completed a $240 million senior secured term loan to fund engineering and early works at the Los Azules copper project, aiming for a final investment decision by mid-2027 and commercial production by 2030. The financing demonstrates confidence in the project and Argentina's improving…

Two Australians Charged Over Alleged Widespread Tampering of Open-Source Tools

Two Australians Charged Over Alleged Widespread Tampering of Open-Source Tools

Australian authorities announced charges against two men accused of involvement in TeamPCP, an alleged hacking collective that injected malicious code into widely used open-source tools. Police say the activity potentially affected more than 1,000 organizations worldwide, leading to the theft of over 500,000 credentials and more than 300 gigabytes …

Alamos Gold Declares Quarterly Dividend

Alamos Gold Declares Quarterly Dividend

Alamos Gold Inc. has declared a quarterly dividend of US$0.04 per common share, continuing its tradition of paying dividends for 17 consecutive years. The company has returned $106 million to shareholders in 2026 through dividends and share buybacks. The dividend is payable on September 24, 2026, to shareholders of record on September 10, 2026. A d…

Capital Southwest Announces Quarterly Regular Dividend for the Quarter Ending December 31, 2026 and Quarterly Supplemental Dividend Payable on December 31, 2026

Capital Southwest Announces Quarterly Regular Dividend for the Quarter Ending December 31, 2026 and Quarterly Supplemental Dividend Payable on December 31, 2026

Capital Southwest Corporation, a Nasdaq-listed business development company specializing in middle market financing, announced a quarterly regular dividend of $0.58 per share and a supplemental dividend of $0.06 per share for the quarter ending December 31, 2026. The regular dividend will be paid monthly in October, November, and December, with the…

Exascale Labs Holdings Inc. Announces Closing of Business Combination with D. Boral ARC Acquisition I Corp. and Commencement of Trading on Nasdaq Under Ticker Symbol “XLAB”

Exascale Labs Holdings Inc. Announces Closing of Business Combination with D. Boral ARC Acquisition I Corp. and Commencement of Trading on Nasdaq Under Ticker Symbol “XLAB”

Exascale Labs Holdings Inc., a next-generation AI compute infrastructure provider, has closed its business combination with special purpose acquisition company D. Boral ARC Acquisition I Corp. The combined company will begin trading on Nasdaq under the ticker "XLAB" on August 28, 2026. Exascale operates an asset-light, scalable GPU compute platform…